7Baggers

Avanos Medical Quarterly Income Statements Chart

Quarterly
 | 
Annual
 
 Gross Profit  
 Operating Profit  
 Net Income  
20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 20240331 20240630 20240930 20241231 20250331 20250630 -418.5-342.01-265.53-189.04-112.56-36.0740.41116.9Milllion

Avanos Medical Quarterly Income Statements Table

Quarterly
 | 
Annual
 
Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 
                                              
  net sales175,000,000 167,500,000 179,600,000 170,400,000 171,700,000 166,100,000 173,300,000 171,300,000 169,400,000 191,700,000 217,500,000 202,100,000 203,000,000 197,400,000 193,400,000 184,100,000 186,400,000 180,700,000 185,000,000 185,700,000 163,700,000 180,400,000 189,800,000 171,400,000 172,200,000 164,200,000 169,900,000 165,100,000 160,900,000 156,400,000 -584,600,000 401,400,000 399,200,000 395,600,000 410,000,000 397,500,000 400,000,000 384,800,000 401,400,000 389,500,000 389,300,000 394,200,000 439,400,000 408,500,000 
  cost of products sold82,900,000 77,700,000 81,600,000 77,500,000 76,100,000 71,300,000 78,300,000 75,800,000 71,600,000 87,200,000 100,600,000 92,000,000 88,100,000 90,200,000 96,500,000 93,700,000 100,700,000 89,400,000 96,100,000 89,900,000 77,200,000 78,300,000 80,100,000 76,400,000 73,500,000 65,400,000 69,500,000 60,400,000 66,200,000 65,300,000 -490,700,000 258,100,000 254,600,000 252,700,000 267,300,000 259,500,000 259,300,000 248,300,000 193,750,000 258,500,000 254,400,000 262,100,000 210,150,000 276,300,000 
  gross profit92,100,000 89,800,000 98,000,000 92,900,000 95,600,000 94,800,000 95,000,000 95,500,000 97,800,000 104,500,000 116,900,000 110,100,000 114,900,000 107,200,000 96,900,000 90,400,000 85,700,000 91,300,000 88,900,000 95,800,000 86,500,000 102,100,000 109,700,000 95,000,000 98,700,000 98,800,000 100,400,000 104,700,000 94,700,000 91,100,000 -93,900,000 143,300,000 144,600,000 142,900,000 142,700,000 138,000,000 140,700,000 136,500,000 133,600,000 131,000,000 134,900,000 132,100,000 156,500,000 132,200,000 
  yoy-3.66% -5.27% 3.16% -2.72% -2.25% -9.28% -18.73% -13.26% -14.88% -2.52% 20.64% 21.79% 34.07% 17.42% 9.00% -5.64% -0.92% -10.58% -18.96% 0.84% -12.36% 3.34% 9.26% -9.26% 4.22% 8.45% -206.92% -26.94% -34.51% -36.25% -165.80% 3.84% 2.77% 4.69% 6.81% 5.34% 4.30% 3.33% -14.63% -0.91%     
  qoq2.56% -8.37% 5.49% -2.82% 0.84% -0.21% -0.52% -2.35% -6.41% -10.61% 6.18% -4.18% 7.18% 10.63% 7.19% 5.48% -6.13% 2.70% -7.20% 10.75% -15.28% -6.93% 15.47% -3.75% -0.10% -1.59% -4.11% 10.56% 3.95% -197.02% -165.53% -0.90% 1.19% 0.14% 3.41% -1.92% 3.08% 2.17% 1.98% -2.89% 2.12% -15.59% 18.38%  
  gross margin %                                            
  research and development5,800,000 5,400,000 5,700,000 7,200,000 6,300,000 7,000,000 6,800,000 6,100,000 6,800,000 7,900,000 7,500,000 7,300,000 8,000,000 7,800,000 7,600,000 8,400,000 8,000,000 8,300,000 9,600,000 8,200,000 7,700,000 9,400,000 8,400,000 9,600,000 9,500,000 10,200,000 10,600,000 10,500,000 10,800,000 9,900,000 10,100,000 10,300,000 9,800,000 8,000,000 12,000,000 10,900,000 9,500,000 8,700,000       
  selling and general expenses83,500,000 75,700,000 79,700,000 74,300,000 80,900,000 83,600,000 74,500,000 78,700,000 93,000,000 92,700,000 82,600,000 82,100,000 87,100,000 90,100,000 75,200,000 75,000,000 76,700,000 73,400,000 82,200,000 82,400,000 76,900,000 91,100,000 103,600,000 94,400,000 94,700,000 106,400,000 87,900,000 86,300,000 79,800,000 86,400,000 19,200,000 101,200,000 100,100,000 101,200,000 110,100,000 100,300,000 107,900,000 92,800,000 98,300,000 97,200,000 105,800,000 97,200,000 126,400,000 111,300,000 
  goodwill impairment77,000,000                                      -1,500,000 475,500,000     
  other income300,000 -1,600,000 -5,600,000 -600,000 2,100,000 200,000 2,500,000 9,500,000 100,000 1,300,000 600,000 2,000,000 800,000 100,000 -10,900,000 3,400,000 8,300,000 22,000,000 41,900,000 5,300,000 3,700,000 1,000,000 900,000 9,100,000 4,300,000 6,800,000 10,200,000 900,000 -4,700,000 1,800,000 4,200,000 3,000,000 5,500,000 7,400,000     -500,000 9,300,000 700,000 -12,000,000   
  operating income-74,500,000 10,300,000 -418,500,000 12,000,000 6,300,000 4,000,000 11,200,000 1,200,000 -2,100,000 2,600,000 26,200,000 18,700,000 19,000,000 9,200,000 25,000,000 3,600,000 -7,300,000  -44,800,000 -100,000 -1,800,000 600,000 -3,200,000 -18,100,000 -9,800,000 -24,600,000 -8,300,000 7,000,000 8,800,000 -7,000,000               
  yoy-1282.54% 157.50% -3836.61% 900.00% -400.00% 53.85% -57.25% -93.58% -111.05% -71.74% 4.80% 419.44% -360.27%  -155.80% -3700.00% 305.56%  1300.00% -99.45% -81.63% -102.44% -61.45% -358.57% -211.36% 251.43%                   
  qoq-823.30% -102.46% -3587.50% 90.48% 57.50% -64.29% 833.33% -157.14% -180.77% -90.08% 40.11% -1.58% 106.52% -63.20% 594.44% -149.32%   44700.00% -94.44% -400.00% -118.75% -82.32% 84.69% -60.16% 196.39% -218.57% -20.45% -225.71%                
  operating margin %                                            
  interest income600,000 1,500,000 800,000 700,000 3,000,000 600,000 1,000,000 900,000 500,000 500,000 700,000 300,000 200,000   200,000   100,000 200,000 200,000 700,000 1,000,000 1,300,000 2,000,000 2,400,000 2,400,000 2,200,000 2,200,000 1,000,000 900,000 700,000 500,000 400,000 100,000 200,000 100,000 200,000 100,000  100,000 100,000  1,000,000 
  interest expense-2,000,000 -2,100,000 -2,800,000 -3,200,000 -3,100,000 -3,100,000 -3,300,000 -4,700,000 -3,500,000 -3,500,000 -3,000,000 -3,000,000 -2,700,000 -1,300,000 -700,000 -900,000 -900,000 -800,000 -2,700,000 -4,300,000 -4,300,000 -4,300,000 -4,300,000 -3,500,000 -3,500,000 -3,700,000 -3,500,000 -4,200,000 -9,900,000 -8,800,000 -8,100,000 -8,100,000 -7,800,000 -7,600,000 -8,000,000 -8,400,000 -8,300,000 -8,000,000 -8,100,000 -7,800,000 -8,900,000 -8,300,000 -5,900,000 -100,000 
  income before income taxes-75,900,000 9,700,000 -420,500,000 9,500,000 6,200,000 1,500,000 8,900,000 -2,600,000 -5,100,000 -400,000 23,900,000 16,000,000 16,500,000 7,900,000 24,300,000 2,900,000 -8,200,000 -13,200,000 -47,400,000 -4,200,000 -5,900,000 -3,000,000 -6,500,000 -20,300,000 -11,300,000 -25,900,000 -9,400,000 5,000,000 1,100,000 -14,800,000 -134,600,000 21,400,000 21,900,000 19,100,000 7,900,000 12,700,000 9,400,000 25,300,000 12,500,000 -469,000,000 13,300,000 32,700,000 18,100,000 14,000,000 
  income tax provision-900,000 -3,100,000 -1,625,000 -3,600,000      -100,000                     -3,975,000 -4,800,000 -4,800,000 -6,300,000 2,100,000 -3,600,000 -2,900,000 -11,100,000       
  income from continuing operations-76,800,000 6,600,000 -397,000,000 5,900,000 4,300,000 500,000 11,000,000 -8,800,000 -4,300,000              -6,100,000 -11,500,000 -8,000,000 -20,300,000 -2,700,000 4,200,000 1,300,000 -11,300,000               
  income from discontinued operations, net of tax  -300,000 -1,600,000 -2,500,000 -1,400,000 -500,000 5,100,000 -63,800,000                  500,000  34,000,000 31,500,000               
  net income-76,800,000 6,600,000 -397,300,000 4,300,000 1,800,000 -900,000 10,500,000 -3,700,000 -68,100,000 -500,000 16,900,000 15,700,000 11,400,000 5,800,000 10,000,000 -35,100,000 37,900,000 -7,600,000 -47,200,000 19,300,000 -3,000,000 3,700,000 -6,100,000 -11,500,000 -8,000,000 -20,300,000 -2,200,000 4,200,000 35,300,000 20,200,000 32,800,000 16,600,000 17,100,000 12,800,000 10,000,000 9,100,000 6,500,000 14,200,000 14,500,000 -470,500,000 8,000,000 21,700,000 -2,400,000 -7,400,000 
  yoy-4366.67% -833.33% -3883.81% -216.22% -102.64% 80.00% -37.87% -123.57% -697.37% -108.62% 69.00% -144.73% -69.92% -176.32% -121.19% -281.87% -1363.33% -305.41% 673.77% -267.83% -62.50% -118.23% 177.27% -373.81% -122.66% -200.50% -106.71% -74.70% 106.43% 57.81% 228.00% 82.42% 163.08% -9.86% -31.03% -101.93% -18.75% -34.56% -704.17% 6258.11%     
  qoq-1263.64% -101.66% -9339.53% 138.89% -300.00% -108.57% -383.78% -94.57% 13520.00% -102.96% 7.64% 37.72% 96.55% -42.00% -128.49% -192.61% -598.68% -83.90% -344.56% -743.33% -181.08% -160.66% -46.96% 43.75% -60.59% 822.73% -152.38% -88.10% 74.75% -38.41% 97.59% -2.92% 33.59% 28.00% 9.89% 40.00% -54.23% -2.07% -103.08% -5981.25% -63.13% -1004.17% -67.57%  
  net income margin %                                            
  basic earnings per share:                                            
  continuing operations-1.66 0.14 -8.63 0.13 0.09 0.01 0.24 -0.19 -0.09              -0.12 -0.24 -0.17 -0.43 -0.06 0.09 0.03 -0.24               
  discontinued operations  -0.01 -0.03 -0.05 -0.03 -0.01 0.11 -1.37                  0.01  0.72 0.67               
  basic earnings per share-1.66 0.14 -8.64 0.1 0.04  0.23 -0.08 -1.46              -0.12 -0.24 -0.17 -0.43 -0.05 0.09 0.75 0.43               
  diluted earnings per share:                                            
  diluted earnings per share-1.66 0.14 -8.64 0.09 0.04  0.23 -0.08 -1.46              -0.12 -0.24 -0.17 -0.43 -0.05 0.09 0.73 0.43               
  income tax benefit    -1,900,000 -1,000,000 2,100,000 -6,200,000 800,000  -7,000,000 -300,000 -5,100,000 -2,100,000 -14,300,000 -38,000,000 46,100,000 5,600,000 200,000 23,500,000 2,900,000 6,700,000 400,000 8,800,000 3,300,000 5,600,000 6,700,000 -800,000 200,000 3,500,000               
  basic loss per share     -0.02                                       
  diluted loss per share     -0.02                                       
  earnings per share                                            
  basic         -0.01 0.178 0.34 0.24 0.12 -0.025 -0.73 0.79 -0.16 0.105 0.4 -0.06 0.08         0.25 0.35 0.37 0.27 0.21 0.19         
  basic earnings per share-1.66 0.14 -8.64 0.1 0.04  0.23 -0.08 -1.46              -0.12 -0.24 -0.17 -0.43 -0.05 0.09 0.75 0.43               
  diluted                                            
  earnings per share                                            
  basic         -0.01 0.178 0.34 0.24 0.12 -0.025 -0.73 0.79 -0.16 0.105 0.4 -0.06 0.08         0.25 0.35 0.37 0.27 0.21 0.19         
  diluted         -0.01 0.178 0.33 0.24 0.12 -0.025 -0.73 0.78 -0.16 0.105 0.4 -0.06 0.08         0.245 0.35 0.36 0.27 0.22 0.19         
  operating profit                 -12,400,000             21,075,000 28,800,000 29,200,000 26,300,000 15,800,000 20,900,000 17,600,000 33,100,000 20,500,000 -461,200,000 22,100,000 40,900,000 24,000,000 13,100,000 
  earnings per share                                            
  basic:                                            
  diluted:                                            
  other income and (income)                                  4,800,000 5,900,000 5,700,000 1,900,000       
  per share basis                                            
  basic                                    0.14 0.3 0.31 -10.1 0.17 0.47   
  diluted                                    0.14 0.3 0.31 -10.1 0.17 0.46   
  research and development expenses                                      5,625,000 10,200,000 6,300,000 6,000,000 6,525,000 8,500,000 
  benefit from income taxes                                      2,000,000 -1,500,000 -5,300,000 -11,000,000 -20,500,000 -21,400,000 
  other (income) and expense                                          -1,400,000 -700,000 

We provide you with 20 years income statements for Avanos Medical stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Avanos Medical stock. Explore the full financial landscape of Avanos Medical stock with our expertly curated income statements.

The information provided in this report about Avanos Medical stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.